A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

NCT06467370 · clinicaltrials.gov ↗
COMPLETED
Status
342
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer

Collaborators